Akebia Therapeutics (AKBA) Tax Rate (2018 - 2026)

Akebia Therapeutics (AKBA) posted quarterly Tax Rate of 1.41% for Q1 2026, up 84.29% quarter-over-quarter from 8.98% in Q4 2025.

Akebia Therapeutics (AKBA) Tax Rate (2018 - 2026) Analysis & Trends

Akebia Therapeutics (AKBA) has reported Tax Rate for 4 consecutive years, with 1.41% the latest figure, recorded in Q1 2026.

In Q1 2026, Tax Rate changed N/A year-over-year to 1.41%; the TTM figure through Mar 2026 stood at 9.33% (changed N/A YoY), while the FY2025 annual figure was 43.64%, changed N/A from the prior year.
Tax Rate climbed to 1.41% in Q1 2026 per AKBA's latest filing, from 8.98% in the prior quarter.
Across five years, Tax Rate topped out at 53.25% in Q3 2025 and bottomed at 8.98% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn	-26.59%
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-30.40%
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn	10.65%
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-85.63%
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	10.97%
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	3.57%
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Akebia Therapeutics	247.60 Mn	92.06 Mn	38.70 Mn	-0.79%

Download Data